The forecast price for Iterum Therapeutics (ITRM) over the next ten trading days is expected to be between $1.07 and $1.171.
- Current Price and Recent Trends: The closing price of ITRM on October 24, 2024, was $1.172. It has shown a 1-week percentage change of 13.59% and a 1-month percentage change of 5.41%3.
ITRM Percentage Change, Percentage Change YoY
- Technical Indicators: The stock's 5-day moving average is $1.13, the 10-day moving average is $1.07, and the 20-day moving average is $1.044. These indicators suggest a short-term upward trend in the stock price.
- Market Sentiment: The market sentiment towards ITRM is bullish, as indicated by the Bullish rating from InvestorsObserver Stock Sentiment Indicator56. This sentiment could contribute to upward pressure on the stock price.
- Upcoming FDA Decision: The FDA is expected to make a decision on the approval of oral sulopenem for the treatment of uUTI by October 25, 202478. This is a significant event that could positively impact the stock if the drug is approved.
- Price Target: The price target set by HC Wainwright is $5.001011, which is significantly higher than the current price, suggesting potential for a substantial upside if the stock reaches this target.
In conclusion, given the current bullish market sentiment, the positive upcoming FDA decision, and the potential for the stock to reach the price target set by HC Wainwright, the forecast price for ITRM in the next ten trading days suggests a possible upside within the range of $1.07 to $1.17. However, it's important to note that stock prices are subject to market fluctuations and uncertainties, and these forecasts are based on current information.
10/25/2024 11:23am
